Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 20
- DOI:
- No doi available
- Key Word:
- breast neoplasms;chromosome fragile sites;tumor suppressor genes;carcinogens
Abstract： Background WWOX and FHIT are two candidate tumor suppressor genes located in active fragile sites, the damage of which has been associated with the development of breast cancer. The association of the expression of these genes and the development of breast cancer has not been fully explored. We evaluated mRNA and protein expression of WWOX and FHIT in breast tissue with normal histological appearances, atypical ductal hyperplasia, ductal carcinoma in situ, and invasive cancer to see if a progressive decline in expression was present.Methods Reverse transcription-polymerase chain reaction and Western blotting were used to evaluate the specimens for mRNA and protein expression, including 28 specimens with normal tissue, 28 specimens with atypical ductal hyperplasia, 33 specimens with ductal carcinoma in situ, and 51 specimens with invasive ductal carcinoma. Results Compared with in situ and invasive cancer specimens, both normal and atypical hyperplasia specimens had greater rates of detectable mRNA (WWOX rate ratio=2.95, 95% CI 1.24-7.08; FHIT rate ratio=4.58, 95% Cl 1.82-11.81) and Western blotting detectable protein (WWOX rate ratio=4.12, 95% Cl 1.63-10.73; FHIT rate ratio=3.76, 95% Cl 1.44-10.06). For both proteins, differences between normal and atypical hyperplasia specimens and between in situ and invasive carcinoma specimens were explainable by chance (P>0.05 for each analysis). Within each histological category, differences among fractions of specimens showed that FHIT and WWOX mRNA. and protein expression were explainable by chance (P >0.05 for each analysis).Conclusion Expression of FHIT and WWOX decreases along with breast tissue progress from a normal histological appearance to atypical ductal hyperplasia, in situ cancer, and the final invasive cancer.
- [1]ZHANG Ming,YAN Ji-dong,Hang Lei,etc.Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen[J].2005,(19).
- [2]XIE Guang-shun,HOU Ai-rong,LI Long-yun,etc.Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer[J].2006,(17).
- [3]HAN Ding-fen,ZHOU Xin,HU Ming-bai,etc.Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study[J].2005,(18).
- [4]HOU Wei-kai,XU Yu-xin,YU Ting,etc.Adipocytokines and breast cancer risk[J].2007,(18).
- [5]LETIZIA SCOLA,MARINA VAGLICA,GIUSI IRMA FORTE,etc.Cytokine Gene Polymorphisms and Breast Cancer Susceptibility[J].2006,1089(nov).
- [6]Mincey BA.Genetics and the management of women at high risk for breast cancer.[J].2003,8(5).
- [7]Mierzejewski M,Nej K,Byrski T,etc.Breast Cancer Risk Reduction Associated with the RAD51 Polymorphism among Carriers of the BRCA1 5382insC Mutation in Poland.[J].2003,12(5).
- [8]van Heerden-WF,Engelbrecht S,van Rensburg-EJ,etc.Immunohistochemical evaluation of Fhit protein expression in oral squamous cell carcinomas.[J].1999,28(10).
- [9]PAOLA MUTI.The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer The Epidemiological Evidence[J].2004,1028(dec).
- [10]Uner A,Guler N,Iliopoulos D,etc.Concordant loss of fragile gene expression early in breast cancer development.[J].2005,55(8).
- [11]Raulet D,Gasser S.The DNA damage response, immunity and cancer.[J].2006,16(5).
- [12]M, Campiglio,Y, Pekarsky,S, Menard,etc.FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.[J].1999,59.
- [13]Zucman-Rossi J,Yakicier MC,Vaury C,etc.Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.[J].2001,20(37).
- [14]Andriani F,Galetti M,Roz L,etc.Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.[J].2004,23(52).
- [15]Gramegna Marcella,Sozzi Gabriella,Ishii Hideshi,etc.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.[J].2002,99(6).
- [16]Doherty J,Chang NS,Ensign A.JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.[J].2003,278(11).
- [17]Arlt MF,Glover TW,Casper AM.Common fragile sites.[J].2003,100(1).
- [18]Beer DavidG,Arlt MartinF,Glover ThomasW,etc.Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells.[J].2002,33(1).
- [19]Huebner K,Croce CM,Sozzi G.Role of FHIT in human cancer.[J].1999,17(5).
- [20]M, Ohta,H, Inoue,M G, Cotticelli,etc.The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3; 8) breakpoint, is abnormal in digestive tract cancers.[J].1996,84.
- [21]D, Capuzzi,E, Santoro,W W, Hauck,etc.Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.[J].2000,88(1).
- [22]K, Huebner,C M, Croce.FRA3B and other common fragile sites: the weakest links.[J].2001,1(3).
- [23]Paige AJ,Gabra H,Watson JE,etc.WWOX: a candidate tumor suppressor gene involved in multiple tumor types.[J].2001,98(20).
- [24]T, Mashimo,M, Watabe,A P, Cuthbert,etc.Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells.[J].1998,58.
- [25]Sandra, Sipeti,Vesna, Petrovi,Zorica, Mili,etc.[Breast cancer incidence among women of Branicevo region in the period 1991-2000].[J].1900,57(9-10).
- [26]G, Sozzi,U, Pastorino,L, Moiraghi,etc.Loss of FHIT function in lung cancer and preinvasive bronchial lesions.[J].1998,58.
- [27]Kaaks R,Rinaldi S,Key TJ,etc.Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.[J].2005,12(4).
- [28]Mukherjee S,Koner BC,Ray S,etc.Environmental contaminants in pathogenesis of breast cancer[J].2006,44(8).
- [29]Gurvich R,Shaham J,Czerniak A,etc.The risk of breast cancer in relation to health habits and occupational exposures.[J].2006,49(12).
- [30]T S, Frank,A M, Deffenbaugh,M, Hulick,etc.Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.[J].1999,15.